Florida medical marijuana advertising rules

In most states a compliance check is a good habit; in Florida it is the process itself. Fla. Stat. 381.986(8)(h) places medical marijuana treatment center advertising under Department of Health approval, so the question is not whether someone will review the copy but whether it survives that review, and the same subsection restricts how marijuana and an MMTC can be visible to the public at all. The Department's content rules now live in Emergency Rule 64ER25-6, MMTC Advertising and Marketing, effective December 31, 2025, administered through the Office of Medical Marijuana Use. For an agency, this changes the economics of a mistake: a flagged draft is not a takedown risk later, it is a rejection at the gate, and every rejection is cycle time on a campaign the client has already paid for. Screening the draft before it goes to the Department is how the approval pass becomes one pass.

The rule's content prohibitions are aimed at keeping medical marijuana medical. No cure claims: nothing may state or imply that a usable marijuana product cures any medical condition, and false or misleading content is barred generally (64ER25-6(3)(a) and (b)). No recreational positioning: the rule bans stating or implying recreational intent and promoting or depicting recreational use, and the statute reaches trade names, logos, and advertising that promote recreational use (64ER25-6(3)(c) and (d); 381.986(8)(h)). Patients only: nothing may state or imply that products are for use by anyone other than a qualified patient, or for any condition other than a qualifying condition under 381.986(2) (64ER25-6(3)(e) and (f)). Nothing attractive to children: childlike images, fonts, candy framing, and deliberate misspellings such as kool or froot are barred (64ER25-6(3)(n) and (o)). No celebrities or influencers, at all: unlike New Mexico's qualified version, Florida's ban is flat and reaches influencers including virtual influencers (64ER25-6(3)(k) and the rule's definitions). And no sourcing claims promoting product from out-of-state sources or from another MMTC (64ER25-6(3)(p)).

64ER25-6 requires five notices, verbatim, in minimum 12-point plain lettering, on printed marketing literature, on the homepage of the department-approved website, and in email solicitations that advertise usable product: that marijuana may have intoxicating effects and may be habit-forming; not to operate a vehicle or heavy machinery under the influence; that smoking marijuana may be hazardous to health; that use while pregnant or breastfeeding may harm you and your baby; and to keep marijuana away from children and pets (64ER25-6(5)(c), (6)(d)2, (6)(e)2). Email has its own gate: marketing must be opt-in with an easy and permanent opt-out (381.986(8)(h)2.d; 64ER25-6(6)(a)4). That is the state-law layer; federal CAN-SPAM applies to the same messages separately, so a compliant Florida MMTC email satisfies both.

Honesty about our own review clock: the Florida medical marijuana ruleset in the Pre-Trip library is drafted from the primary sources above but is still awaiting publisher review. It scans and it surfaces findings with their citations, but under our fail-closed rule an unreviewed ruleset makes a clean pass impossible and the result says why. That is deliberate. In the one state where a regulator reads every ad before it runs, a scanner that hands out clean passes on an unverified rule model would be selling exactly the false comfort Florida's regime exists to prevent. Use the findings as a pre-submission checklist with the citations attached, and take the finished piece to the Department, and to counsel where the call is close.

The Florida tell is positioning: copy that would be ordinary retail marketing in an adult-use state reads as recreational positioning in a medical-only one.

Pre-Trip is a rigorous screen, not legal advice. Counsel decides; we help you arrive prepared.